By The Online Investor Staff, updated Fri., Aug. 1, 3:46 AM
Slide #1. Marinus Pharmaceuticals, Inc. — Initial Public Offering
||Marinus Pharmaceuticals, Inc.
|Price Per Share:
||Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative neuropsychiatric therapeutics, today announced the pricing of its initial public offering of 5,625,000 shares of its common stock at a public offering price of $8.00 per share, before underwriting discounts. The shares are scheduled to begin trading on the NASDAQ Global Market under the ticker symbol "MRNS" on July 31, 2014. In addition, Marinus has granted the underwriters a 30-day option to purchase up to an additional 843,750 shares of common stock at the same price to cover over-allotments, if any. The offering is expected to close on August 5, 2014, subject to customary closing conditions.
IPOs: Marinus Pharmaceuticals, Inc.
List of IPOs in this Slideshow:
Company Ticker IPO Date
Virgin America Inc. T.B.D.
ContraFect Corporation CFRX
Green Bancorp, Inc. GNBC
Bio Blast Pharma Ltd. ORPN
Synchrony Financial SYF
Macrocure Ltd. MCUR
HealthEquity, Inc. HQY
VBL Therapeutics VBLX
Catalent, Inc. CTLT
Avalanche Biotechnologies, Inc. AAVL
Paramount Group, Inc. T.B.D.
Transocean Partners LLC RIGP
TransFirst Inc. T.B.D.
Westlake Chemical Partners LP WLKP
Marinus Pharmaceuticals, Inc. MRNS
August 1, 2014 3:46 AM Eastern